echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The example of Yisuo attaches importance to the management of adverse reactions and ensures the benefit of patients. Analysis of multiple myeloma cases in the elderly

    The example of Yisuo attaches importance to the management of adverse reactions and ensures the benefit of patients. Analysis of multiple myeloma cases in the elderly

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    Multiple myeloma (MM) is a malignant disease in which clonal plasma cells proliferate abnormally, mostly in the elderly




    • Chief Physician, Department of Hematology, Jingzhou First People's Hospital

    • Member of Hubei Provincial Committee of Hematology and Cancer

    • Member of ESCO Hematology and Oncology Committee

    • Member of the Hematology Branch of the Asia-Pacific Society of Medical Bioimmunology

    • Member of the MDS/MPN Branch of the Hematology Committee of the Hubei Medical Bioimmune Society

    • Member of Jingzhou Hematology Branch

    • Specialties: Diagnosis and Treatment of Hematological Tumors and Hematopoietic Stem Cell Transplantation



    • Director of the Department of Hematology, Jingzhou First People's Hospital

    • Member of Hubei Society of Hematology

    • Member of the Standing Committee of Hubei Provincial Society of Clinical Oncology

    • Master tutor of Changjiang University

    • The first top ten doctors in Jingzhou

    • Presided over and participated in 5 provincial and municipal scientific research projects, and won 1 third prize of the provincial scientific and technological progress award.



    • An elderly frail MM patient with renal damage developed peripheral neuropathy (PN) after treatment with bortezomib-based induction regimen.



    The full oral IRd regimen containing ixazomib may bring more treatment options for elderly frail MM patients who have received multi-line therapy, further improve the quality of life of patients, and benefit more patients



    references

    [1] Hervé Avet-Loiseau, et al.



    Edit: Moon Reviewer: Janet Typesetting: moly Execution: moly



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.